Becker's Healthcare January 13, 2021
Katie Adams

The FDA issued a five-pronged action plan to regulate medical products powered by artificial intelligence, the agency announced Jan. 12.

Five measures the FDA plans to take:

  1. Further development of regulatory framework, including draft guidance on a change control plan for AI’s learning over time
  2. Working...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology
Understanding the Value of the Home as a Healthcare Site
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?

Share This Article